BASEL, SWITZERLAND – Novartis will cut 500 jobs, mostly in the Basel area, in 2014, while creating about the same number of jobs to push new pharmaceutical products, the company said Tuesday.
It put the emphasis on status quo for staffing numbers this year, following five years of consecutive growth in jobs, noting that in 2013, 750 new jobs were created, bringing to 15,000 the total.
Of the 4,000 new jobs created in the past eight years, the firm says, most have been in the Basel area.
The Nyon site will see jobs added, with a third over-the-counter production area added.
Most of the jobs lost will be in head office support for the pharmaceuticals division.
The new jobs will be in the areas of brand and generic medicines for respiratory ailments, pulmonary cancer, dermatology and heart disease.